AS Latvijas Juras medicinas centrs (MUN:UOM)
Germany · Delayed Price · Currency is EUR 7.40
-0.45 (-5.73%)
Inactive · Last trade price on Mar 9, 2026
MUN:UOM Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1.15 | 0.86 | 0.67 | 1.32 | 1.02 |
Cash & Short-Term Investments | 1.15 | 0.86 | 0.67 | 1.32 | 1.02 |
Cash Growth | 33.36% | 28.03% | -48.93% | 29.90% | -42.37% |
Accounts Receivable | 0.1 | 0.42 | 0.4 | 0.43 | 0.1 |
Other Receivables | 0.18 | 0.04 | 0.02 | 0.02 | 0.46 |
Receivables | 0.28 | 0.46 | 0.42 | 0.46 | 0.56 |
Inventory | 0.13 | 0.13 | 0.16 | 0.14 | 0.16 |
Prepaid Expenses | 0.01 | 0 | 0.01 | - | 0.01 |
Other Current Assets | - | - | - | 0.57 | 0.57 |
Total Current Assets | 1.58 | 1.46 | 1.27 | 2.49 | 2.31 |
Property, Plant & Equipment | 7.09 | 7.59 | 7.79 | 6.35 | 5.94 |
Other Long-Term Assets | 0.06 | - | - | - | - |
Total Assets | 8.73 | 9.06 | 9.05 | 8.85 | 8.26 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.24 | 0.66 | 0.62 | 0.45 | 0.3 |
Accrued Expenses | 0.94 | 1.1 | 1.04 | 0.84 | 0.81 |
Current Income Taxes Payable | - | 0 | 0 | 0 | 0 |
Current Unearned Revenue | 0.09 | 0.07 | 0.06 | 0.06 | 0.06 |
Other Current Liabilities | 0.56 | 0.11 | 0.14 | 0.13 | 0.11 |
Total Current Liabilities | 1.83 | 1.94 | 1.86 | 1.47 | 1.29 |
Long-Term Unearned Revenue | 0.57 | 0.64 | 0.51 | 0.57 | 0.63 |
Other Long-Term Liabilities | - | 0.1 | 0.48 | - | - |
Total Liabilities | 2.4 | 2.68 | 2.85 | 2.04 | 1.92 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1.12 | 1.12 | 1.12 | 1.12 | 1.12 |
Retained Earnings | 2.63 | 2.69 | 2.51 | 3.21 | 2.75 |
Comprehensive Income & Other | 2.57 | 2.57 | 2.57 | 2.47 | 2.47 |
Total Common Equity | 6.33 | 6.38 | 6.2 | 6.81 | 6.34 |
Shareholders' Equity | 6.33 | 6.38 | 6.2 | 6.81 | 6.34 |
Total Liabilities & Equity | 8.73 | 9.06 | 9.05 | 8.85 | 8.26 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash (Debt) | 1.15 | 0.86 | 0.67 | 1.32 | 1.02 |
Net Cash Growth | 33.36% | 28.03% | -48.93% | 29.90% | -42.37% |
Net Cash Per Share | 1.44 | 1.08 | 0.84 | 1.65 | 1.27 |
Filing Date Shares Outstanding | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 |
Total Common Shares Outstanding | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 |
Working Capital | -0.25 | -0.48 | -0.6 | 1.02 | 1.03 |
Book Value Per Share | 7.91 | 7.98 | 7.75 | 8.51 | 7.93 |
Tangible Book Value | 6.33 | 6.38 | 6.2 | 6.81 | 6.34 |
Tangible Book Value Per Share | 7.91 | 7.98 | 7.75 | 8.51 | 7.93 |
Land | - | 5.68 | 5.68 | 5.46 | 5.46 |
Machinery | - | 6.15 | 5.84 | 4.04 | 3.38 |
Construction In Progress | - | - | - | 0.08 | 0.07 |